Metraipolis › archive › dc_238d5b2ef515

Integrating molecular targeting and immune modulation in triple-negative breast cancer: from mechanistic insights to therapeutic innovation — Europe PMC PMID:41383624

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41383624
DOI
10.3389/fimmu.2025.1711415
License (as archived)
solo-consultazione
Archived
2026-11-08T05:41:20.466Z
SHA-256 of the archived text
1f846e65da4c35f734a5f863bc35e0c47485ea1b6eef421432bd9d642b6e07fc
Stable URL of this page
https://metraipolis.com/documento/dc_238d5b2ef515

How to cite

Integrating molecular targeting and immune modulation in triple-negative breast cancer: from mechanistic insights to therapeutic innovation — Europe PMC PMID:41383624 — Europe PMC (en), https://europepmc.org/article/MED/41383624 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_238d5b2ef515 (Metraipolis archive dc_238d5b2ef515, sha256 1f846e65da4c35f734a5f863bc35e0c47485ea1b6eef421432bd9d642b6e07fc)
BibTeX
@misc{dc238d5b2ef515,
  title = {Integrating molecular targeting and immune modulation in triple-negative breast cancer: from mechanistic insights to therapeutic innovation — Europe PMC PMID:41383624},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41383624},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_238d5b2ef515; sha256 1f846e65da4c35f734a5f863bc35e0c47485ea1b6eef421432bd9d642b6e07fc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41383624. Agents can read the archived copy with the MCP tool read_document.